Literature DB >> 10942851

Neurosteroids ameliorate conditioned fear stress: an association with sigma receptors.

Y Noda1, H Kamei, Y Kamei, T Nagai, M Nishida, T Nabeshima.   

Abstract

Mice exhibited a marked suppression of motility (conditioned fear stress) when placed in an environment in which they had previously received an electric footshock. This conditioned fear stress response was dose-dependently attenuated by neurosteroids such as dehydroepiandrosterone sulfate (DHEAS; 25 and 50 mg/kg, s.c.) and pregnenolone sulfate (PREGS; 10-50 mg/kg, s.c.), and by a putative sigma(1) receptor agonist, (+)-N-allylnormetazocine ((+)-SKF-10,047; 3 and 6 mg/kg, s.c.). However, progesterone (PROG; 10-50 mg/kg, s.c. ) and allopregnanolone (5 and 20 mg/kg, s.c.) had no effect on this stress response. The attenuating effects of DHEAS (50 mg/kg, s.c.), PREGS (50 mg/kg, s.c.), and (+)-SKF-10,047 (6 mg/kg, s.c.) were reversed by NE-100 (5 mg/kg, i.p.), a sigma(1) receptor antagonist and PROG (5 or 10 mg/kg, i.p.). When DHEAS (25 mg/kg) was co-administered with (+)-SKF-10,047 (3 mg/kg) at doses that do not affect the conditioned fear stress response by themselves, motor suppression was significantly attenuated. In mice showing the conditioned fear stress response, the serum concentration of DHEAS was lower than that in non-shocked mice. These results suggest that the attenuating effects of DHEAS and PREGS on the conditioned fear stress response are mediated via sigma(1) receptors and that PROG has a sigma(1) receptor antagonistic property. Further, the endogenous DHEAS may be involved in the expression of conditioned fear stress response in mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942851     DOI: 10.1016/S0893-133X(00)00103-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  11 in total

1.  Cortisol, dehydroepiandrosterone sulphate and dehydroepiandrosterone sulphate/cortisol ratio responses to physical stress in males are influenced by pubertal development.

Authors:  L Di Luigi; L Guidetti; C Baldari; M C Gallotta; P Sgrò; F Perroni; F Romanelli; A Lenzi
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

3.  Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Jenna Ford; Jessica A Rogers; Stacey Scheick; Yue Ji; Mahendra Bishnoi; Jon C Alexander
Journal:  Pharmacol Biochem Behav       Date:  2011-12-09       Impact factor: 3.533

Review 4.  Gut feelings: the microbiota-gut-brain axis on steroids.

Authors:  Sik Yu So; Tor C Savidge
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-03       Impact factor: 4.052

5.  Sigma-1 receptor knockout mice display a depressive-like phenotype.

Authors:  Valentina Sabino; Pietro Cottone; Sarah L Parylak; Luca Steardo; Eric P Zorrilla
Journal:  Behav Brain Res       Date:  2008-11-30       Impact factor: 3.332

6.  Neurosteroids as neuromodulators in the treatment of anxiety disorders.

Authors:  Patrizia Longone; Flavia di Michele; Elisa D'Agati; Elena Romeo; Augusto Pasini; Rainer Rupprecht
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-19       Impact factor: 5.555

7.  Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.

Authors:  Tomoko Nishimura; Tamaki Ishima; Masaomi Iyo; Kenji Hashimoto
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

8.  Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.

Authors:  William Davies; Trevor Humby; Wendy Kong; Tamara Otter; Paul S Burgoyne; Lawrence S Wilkinson
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

9.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

10.  Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.

Authors:  Mikhail V Voronin; Yulia V Vakhitova; Inna P Tsypysheva; Dmitry O Tsypyshev; Inna V Rybina; Rustam D Kurbanov; Elena V Abramova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.